The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Impact of obesity and overweight on DNA stability: Few facts and many hypotheses
Year: 
2018
Journal: 
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
Setayesh, T; Nersesyan, A; Misik, M; Ferk, F; Langie, S; Andrade, VM; Haslberger, A; Knasmuller, S
Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium
Year: 
2018
Journal: 
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Felix, JF; Joubert, BR; Baccarelli, AA; Sharp, GC; Almqvist, C; Annesi-Maesano, I; Arshad, H; Baiz, N; Bakermans-Kranenburg, MJ; Bakulski, KM; Binder, EB; Bouchard, L; Breton, CV; Brunekreef, B; Brunst, KJ; Burchard, EG; Bustamante, M; Chatzi, L; Munthe-K

Pages